00000000|MMI|12.93|Fibromyalgia|C0016053|[dsyn]|["FIBROMYALGIA"-tx-1-"fibromyalgia"-noun-0]|TX|66/12|C05.651.324;C05.799.321;C10.668.491.425
00000000|MMI|7.08|20%|C3842589|[fndg]|["20%"-tx-1-"20"-fraction-0]|TX|[44/2],[108/2]|
00000000|MMI|3.68|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|89/14|
00000000|MMI|3.68|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|89/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|116/13|
00000000|MMI|3.64|10 - 12|C3843787|[fndg]|["10 - 12"-tx-1-"10 12"-fraction-0]|TX|41/2,52/2|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.47|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|83/3|
00000000|MMI|3.47|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|83/3|
00000000|MMI|3.46|10%|C3842590|[fndg]|["10%"-tx-1-"10"-fraction-0]|TX|105/2|
00000000|MMI|117.54|Portugal|C0032729|[geoa]|["PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|2315/2;[1031/2],[1110/2],[1966/2],[2040/2],[2177/2];[445/2],[555/2],[666/2],[709/2],[836/2]|Z01.542.727
00000000|MMI|116.92|Daily|C0332173|[tmco]|["QD"-tx-24-"qd"-noun-0,"QD"-tx-12-"qd"-noun-0,"Daily"-tx-3-"DAILY"-adj-0,"Daily"-tx-3-"DAILY"-adv-0,"Daily"-tx-2-"DAILY"-adj-0,"Daily"-tx-2-"DAILY"-adv-0,"QD"-tx-2-"qd"-noun-0]|TX|4587/2;[3594/2],[3693/2],[3712/2],[3730/2],[3781/2],[3799/2],[3834/2];[2043/5],[2180/5];[2043/5],[2180/5];[448/5],[598/5],[669/5],[839/5];[448/5],[598/5],[669/5],[839/5];994/2|
00000000|MMI|86.83|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-37-"DISCHARGE"-noun-0,"Discharge"-tx-33-"DISCHARGE"-noun-0,"Discharge"-tx-5-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|5638/9;5452/9;2597/9;39/9;152/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|84.70|Mongolia|C0026410|[geoa]|["MG"-tx-4-"MG"-noun-0,"MG"-tx-3-"MG"-noun-0,"MG"-tx-2-"MG"-noun-0]|TX|2312/2;[1028/2],[1084/2],[2037/2];[428/2],[663/2],[833/2]|Z01.252.474.651
00000000|MMI|75.87|Obesity|C0028754|[dsyn]|["OBESE"-tx-12-"obese"-adj-0,"OBESITY"-tx-11-"Obesity"-noun-0,"OBESITY"-tx-5-"obesity"-noun-0]|TX|3910/5;3484/7;2800/7|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|73.12|Fibromyalgia|C0016053|[dsyn]|["FIBROMYALGIA"-tx-21-"fibromyalgia"-noun-0,"FIBROMYALGIA"-tx-5-"Fibromyalgia"-noun-0,"FIBROMYALGIA"-tx-5-"fibromyalgia"-noun-0]|TX|4229/12;2574/12;[2666/12],[2847/12],[2862/12],[3095/12]|C05.651.324;C05.799.321;C10.668.491.425
00000000|MMI|72.90|Pain|C0030193|[sosy]|["PAIN"-tx-27-"pain"-noun-0,"PAIN"-tx-22-"pain"-noun-0,"PAIN"-tx-20-"Pain"-noun-0,"PAIN"-tx-3-"Pain"-noun-0]|TX|4721/4;[4329/4],[4351/4];4067/4;1121/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|67.66|Zoloft|C0284660|[orch,phsu]|["Zoloft"-tx-30-"zoloft"-noun-0,"Zoloft"-tx-12-"Zoloft"-noun-0,"Zoloft"-tx-3-"ZOLOFT"-noun-0]|TX|5238/6;3770/6;2148/6|D02.092.705.800;D02.455.426.559.847.638.845.800;D04.615.638.845.800
00000000|MMI|63.07|Togo|C0040363|[geoa]|["TO"-tx-27-"to"-adv-0,"TO"-tx-13-"to"-adv-0,"TO"-tx-6-"to"-adv-0,"TO"-tx-2-"to"-adv-0]|TX|4853/2;3949/2;3184/2;897/2|Z01.058.290.190.800
00000000|MMI|63.07|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-27-"to"-adv-0,"TO"-tx-13-"to"-adv-0,"TO"-tx-6-"to"-adv-0,"TO"-tx-2-"to"-adv-0]|TX|4853/2;3949/2;3184/2;897/2|D08.811.520.224.800
00000000|MMI|59.16|Insulin|C0021641|[aapp,horm,phsu]|["INSULIN"-tx-31-"insulin"-noun-0,"INSULIN"-tx-3-"insulin"-noun-0]|TX|5311/7;[1383/7],[1803/7]|D06.472.699.587.200.500.625;D12.644.548.586.200.500.625
00000000|MMI|59.14|NovoLog|C0939412|[aapp,phsu]|["NovoLog"-tx-12-"Novolog"-noun-0,"NovoLog"-tx-3-"NOVOLOG"-noun-0]|TX|3636/7;[1126/7],[1198/7]|D06.472.699.587.200.400.100;D12.644.548.586.200.400.100
00000000|MMI|57.44|Dominican Republic|C0013014|[geoa]|["DR"-tx-34-"Dr"-noun-0,"DR"-tx-33-"dr"-noun-0,"DR"-tx-24-"Dr"-noun-0,"DR"-tx-4-"Dr"-noun-0]|TX|5524/2;5501/2;4652/2;2472/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|50.98|Seroquel|C0287163|[orch,phsu]|["Seroquel"-tx-30-"seroquel"-noun-0,"Seroquel"-tx-12-"Seroquel"-noun-0,"Seroquel"-tx-3-"SEROQUEL"-noun-0]|TX|5227/8;3786/8;2009/8|D02.886.680.702.500.500;D03.494.276.500
00000000|MMI|50.60|Prednisone|C0032952|[horm,orch,phsu]|["PREDNISONE"-tx-27-"prednisone"-noun-0,"PREDNISONE"-tx-24-"prednisone"-noun-0,"PREDNISONE"-tx-3-"PREDNISONE"-noun-0]|TX|4742/10;4571/10;1985/10|D04.808.745.432.719.702
00000000|MMI|50.57|Acid Ceramidase|C2350443|[aapp,enzy]|["AC"-tx-12-"AC"-noun-0,"AC"-tx-3-"AC"-noun-0]|TX|3648/2;[1165/2],[1261/2]|D08.811.277.087.250.100
00000000|MMI|46.27|Physicians|C0031831|[prog]|["DR"-tx-34-"Dr"-noun-0,"DR"-tx-33-"dr"-noun-0,"DR"-tx-24-"Dr"-noun-0,"DR"-tx-4-"Dr"-noun-0]|TX|5524/2;5501/2;4652/2;2472/2|M01.526.485.810;N02.360.810
00000000|MMI|46.00|Mental Depression|C0011570|[mobd]|["DEPRESSION"-tx-30-"Depression"-noun-0,"DEPRESSION"-tx-11-"Depression"-noun-0,"DEPRESSION"-tx-5-"depression"-noun-0,"DEPRESSION"-tx-3-"depression"-noun-0]|TX|5165/10;3515/10;2808/10;2092/10|F01.145.126.350
00000000|MMI|44.53|Elavil|C0087119|[orch,phsu]|["Elavil"-tx-30-"elavil"-noun-0,"Elavil"-tx-12-"Elavil"-noun-0]|TX|5218/6;3582/6|D02.455.426.559.847.181.384.100;D04.615.181.384.100
00000000|MMI|44.51|Ipratropium|C0027235|[orch,phsu]|["IPRATROPIUM"-tx-3-"IPRATROPIUM"-noun-0,"IPRATROPIUM"-tx-2-"IPRATROPIUM"-noun-0]|TX|1912/11;477/11|D02.145.074.722.229.400;D03.132.760.180.572.400;D03.132.889.180.648.400;D03.605.869.229.400;D04.075.080.875.099.722.229.400
00000000|MMI|42.77|Buspar|C0600122|[orch,phsu]|["BuSpar"-tx-30-"buspar"-noun-0,"BuSpar"-tx-12-"Buspar"-noun-0,"BuSpar"-tx-2-"BUSPAR"-noun-0]|TX|5251/6;3824/6;635/6|D02.455.426.779.120;D03.383.606.210;D03.383.742.120;D04.711.120
00000000|MMI|42.27|Antigua and Barbuda|C0003354|[geoa]|["AC"-tx-12-"AC"-noun-0,"AC"-tx-3-"AC"-noun-0]|TX|3648/2;[1165/2],[1261/2]|Z01.107.084.900.050;Z01.639.880.050
00000000|MMI|42.27|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-3-"SC"-noun-0]|TX|[1162/2],[1258/2],[1848/2]|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|41.95|Insulin Aspart|C1708521|[aapp,horm,phsu]|["Insulin Aspart"-tx-3-"INSULIN ASPART"-noun-0]|TX|[1136/14],[1208/14]|D06.472.699.587.200.400.100;D12.644.548.586.200.400.100
00000000|MMI|41.95|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-5-"DIAGNOSIS"-noun-0]|TX|[2563/9],[2685/9]|x.x.x.x.x.x.x
00000000|MMI|41.63|Oral|C0442027|[spco]|["PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|2315/2;[1031/2],[1110/2],[1966/2],[2040/2],[2177/2];[445/2],[555/2],[666/2],[709/2],[836/2]|
00000000|MMI|39.86|Then|C1883708|[tmco]|["Then"-tx-28-"then"-adv-0,"Then"-tx-3-"then"-adv-0]|TX|5050/4;[1329/4],[1410/4],[1462/4],[1514/4],[1566/4],[1618/4],[1670/4]|
00000000|MMI|39.04|Lantus|C0876064|[aapp,phsu]|["Lantus"-tx-12-"Lantus"-noun-0,"Lantus"-tx-3-"LANTUS"-noun-0]|TX|3619/6;1811/6|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|39.00|Coding|C0009219|[ocac]|["code"-tx-2-"CODE"-noun-0,"code"-tx-2-"code"-noun-0]|TX|309/4;327/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|38.51|Dyspnea|C0013404|[sosy]|["SHORTNESS OF BREATH"-tx-32-"shortness of breath"-noun-0,"SOB"-tx-9-"SOB"-noun-0,"SHORTNESS OF BREATH"-tx-2-"shortness of breath"-noun-0]|TX|5430/19;3370/3;905/19|C08.618.326;C23.888.852.371
00000000|MMI|36.12|Biospecimen Domain|C3814390|[inpr]|["BS"-tx-3-"BS"-noun-0]|TX|[1288/2],[1307/2],[1394/2],[1446/2],[1498/2],[1550/2],[1602/2],[1654/2],[1714/2]|
00000000|MMI|36.12|Black Swiss Mouse|C4049076|[mamm]|["BS"-tx-3-"BS"-noun-0]|TX|[1288/2],[1307/2],[1394/2],[1446/2],[1498/2],[1550/2],[1602/2],[1654/2],[1714/2]|
00000000|MMI|36.12|Bug Search Subtest (WPPSI-IV)|C4050217|[inpr]|["BS"-tx-3-"BS"-noun-0]|TX|[1288/2],[1307/2],[1394/2],[1446/2],[1498/2],[1550/2],[1602/2],[1654/2],[1714/2]|
00000000|MMI|34.83|Depressive disorder|C0011581|[mobd]|["-- Depression"-tx-30-"Depression"-noun-0,"-- Depression"-tx-11-"Depression"-noun-0,"-- Depression"-tx-5-"depression"-noun-0,"-- Depression"-tx-3-"depression"-noun-0]|TX|5165/10;3515/10;2808/10;2092/10|F03.600.300
00000000|MMI|33.94|Rehabilitation therapy|C0034991|[topp]|["Rehab"-tx-27-"rehab"-noun-0,"Rehabilitation"-tx-2-"Rehabilitation"-noun-0,"Rehab"-tx-1-"rehab"-noun-0]|TX|4804/5;345/14;214/5|E02.831;H02.403.680.600;N02.421.784
00000000|MMI|33.77|Dilaudid|C0728755|[orch,phsu]|["Dilaudid"-tx-22-"dilaudid"-noun-0,"Dilaudid"-tx-12-"Dilaudid"-noun-0]|TX|4419/8;3562/8|D03.132.577.249.562.450;D03.549.686.607.500;D03.605.497.607.500;D04.615.723.795.576.450
00000000|MMI|33.59|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-12-"Lasix"-noun-0,"Lasix"-tx-2-"LASIX"-noun-0]|TX|3683/5;809/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|33.46|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-12-"Atenolol"-noun-0,"ATENOLOL"-tx-2-"ATENOLOL"-noun-0]|TX|3717/8;579/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|28.36|Lesotho|C0023376|[geoa]|["LT"-tx-2-"lt"-noun-0]|TX|[617/2],[629/2]|Z01.058.290.175.400
00000000|MMI|28.13|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-31-"regimen"-noun-0,"Regimen"-tx-30-"regimen"-noun-0]|TX|5319/7;5207/7|E02.183;N05.715.360.775.225
00000000|MMI|27.98|Trazodone|C0040805|[orch,phsu]|["TRAZODONE"-tx-12-"Trazodone"-noun-0,"TRAZODONE"-tx-4-"TRAZODONE"-noun-0]|TX|3804/9;2298/9|D03.383.606.900;D03.383.725.791.900
00000000|MMI|27.97|Fluorides|C0016327|[inch,phsu]|["F-"-tx-33-"f"-noun-0,"F-"-tx-7-"F"-noun-0]|TX|5492/1;3265/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|27.96|Sleeplessness|C0917801|[sosy]|["INSOMNIA"-tx-4-"Insomnia"-noun-0,"INSOMNIA"-tx-2-"Insomnia"-noun-0]|TX|2330/8;570/8|C10.886.425.800.800;F03.870.400.800.800
00000000|MMI|27.90|isoniazid|C0022209|[orch,phsu]|["ISONIAZID"-tx-3-"INH"-noun-0,"ISONIAZID"-tx-2-"INH"-noun-0]|TX|1941/3;801/3|D02.442.436;D03.066.349.410;D03.383.725.394.582
00000000|MMI|27.55|Unit|C0439148|[qnco]|["UNITS"-tx-3-"UNITS"-noun-0,"UNITS"-tx-3-"units"-noun-0]|TX|[1156/5],[1842/5];[1422/5],[1474/5],[1526/5],[1578/5],[1630/5],[1682/5]|
00000000|MMI|27.55|Unit - NCI Thesaurus Property|C3853603|[ftcn]|["Units"-tx-3-"UNITS"-noun-0,"Units"-tx-3-"units"-noun-0]|TX|[1156/5],[1842/5];[1422/5],[1474/5],[1526/5],[1578/5],[1630/5],[1682/5]|
00000000|MMI|27.55|Unit of Measure|C1519795|[qnco]|["Units"-tx-3-"UNITS"-noun-0,"Units"-tx-3-"units"-noun-0]|TX|[1156/5],[1842/5];[1422/5],[1474/5],[1526/5],[1578/5],[1630/5],[1682/5]|
00000000|MMI|26.35|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-3-"grapefruit"-noun-0]|TX|2255/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|26.02|Give - dosing instruction imperative|C1947971|[ftcn]|["Give"-tx-3-"give"-verb-0]|TX|[1415/4],[1467/4],[1519/4],[1571/4],[1623/4],[1675/4],[1744/4]|
00000000|MMI|25.48|Consultation|C0009818|[hlca]|["Consult"-tx-24-"consult"-verb-0,"Consult"-tx-22-"consult"-verb-0]|TX|4522/7;4356/7|N04.452.758.849
00000000|MMI|23.62|Sertraline|C0074393|[orch,phsu]|["SERTRALINE"-tx-3-"SERTRALINE"-noun-0]|TX|2157/10|D02.092.705.800;D02.455.426.559.847.638.845.800;D04.615.638.845.800
00000000|MMI|23.02|100%|C3817553|[qnco]|["100%"-tx-12-"100"-integer-0,"100%"-tx-3-"100"-integer-0,"100%"-tx-2-"100"-integer-0]|TX|[3726/3],[3795/3];[1024/3],[2033/3];[588/3],[620/3],[702/3]|
00000000|MMI|22.98|Honduras|C0019905|[geoa]|["HO"-tx-3-"HO"-noun-0]|TX|[1282/2],[1708/2]|Z01.107.169.534
00000000|MMI|22.75|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-4-"MG"-noun-0,"Mg++"-tx-3-"MG"-noun-0,"Mg++"-tx-2-"MG"-noun-0]|TX|2312/2;[1028/2],[1084/2],[2037/2];[428/2],[663/2],[833/2]|
00000000|MMI|22.75|Milligram percent|C1960952|[qnco]|["mg %"-tx-4-"MG"-noun-0,"mg %"-tx-3-"MG"-noun-0,"mg %"-tx-2-"MG"-noun-0]|TX|2312/2;[1028/2],[1084/2],[2037/2];[428/2],[663/2],[833/2]|
00000000|MMI|22.75|mg/dL|C0439269|[qnco]|["mg%"-tx-4-"MG"-noun-0,"mg%"-tx-3-"MG"-noun-0,"mg%"-tx-2-"MG"-noun-0]|TX|2312/2;[1028/2],[1084/2],[2037/2];[428/2],[663/2],[833/2]|
00000000|MMI|22.60|Panama|C0030266|[geoa]|["PM"-tx-37-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|5621/2;191/2|Z01.107.169.772
00000000|MMI|22.57|Polymyalgia Rheumatica|C0032533|[dsyn]|["pmr"-tx-24-"PMR"-noun-0,"POLYMYALGIA RHEUMATICA"-tx-21-"Polymyalgia rheumatica"-noun-0]|TX|4603/3;4290/22|C05.651.742;C05.799.720;C17.300.775.720
00000000|MMI|22.14|Atrovent|C0591130|[orch,phsu]|["Atrovent"-tx-12-"Atrovent"-noun-0]|TX|3665/8|D02.145.074.722.229.400;D03.132.760.180.572.400;D03.132.889.180.648.400;D03.605.869.229.400;D04.075.080.875.099.722.229.400
00000000|MMI|22.12|Amitriptyline Hydrochloride|C0700523|[orch,phsu]|["amitriptyline hcl"-tx-2-"AMITRIPTYLINE HCL"-noun-0]|TX|531/17|D02.455.426.559.847.181.384.100;D04.615.181.384.100
00000000|MMI|22.11|Simvastatin|C0074554|[orch,phsu]|["SIMVASTATIN"-tx-3-"SIMVASTATIN"-noun-0]|TX|2186/11|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|20.88|Insulin Glargine|C0907402|[aapp,horm,phsu]|["INSULIN GLARGINE"-tx-3-"INSULIN GLARGINE"-noun-0]|TX|1820/16|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|20.88|Surgical aspects|C0038895|[ftcn]|["operations"-tx-5-"OPERATIONS"-noun-0]|TX|2906/10|x.x.x.x.x.x.x
00000000|MMI|19.51|Advair Diskus|C0939246|[orch,phsu]|["Advair Diskus"-tx-2-"ADVAIR DISKUS"-noun-0]|TX|742/13|D02.033.100.291.057.750.500;D02.092.063.291.057.750.500;D02.092.471.683.061.750.500;D04.808.054.079.129.114.500;D26.310.438
00000000|MMI|19.40|Advair|C0965130|[orch,phsu]|["Advair"-tx-12-"Advair"-noun-0]|TX|3658/6|D02.033.100.291.057.750.500;D02.092.063.291.057.750.500;D02.092.471.683.061.750.500;D04.808.054.079.129.114.500;D26.310.438
00000000|MMI|19.39|Hydrocodone|C0020264|[orch,phsu]|["Hydrocodon"-tx-3-"HYDROCODONE"-noun-0]|TX|1070/11|D03.132.577.249.562.149.287;D03.549.686.607.204.540;D03.605.497.607.204.540;D04.615.723.795.576.149.287
00000000|MMI|19.38|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-5-"Treatment"-noun-0]|TX|2747/9|x.x.x.x.x.x.x
00000000|MMI|19.14|10%|C3842590|[fndg]|["10%"-tx-12-"10"-integer-0,"10%"-tx-3-"10"-integer-0,"10%"-tx-2-"10"-integer-0,"10%"-tx-1-"10"-fraction-0]|TX|3743/2;[1153/2],[1996/2],[2145/2];867/2;174/2|
00000000|MMI|18.36|To|C1883351|[qlco]|["To"-tx-27-"to"-adv-0,"To"-tx-13-"to"-adv-0,"To"-tx-6-"to"-adv-0,"To"-tx-2-"to"-adv-0]|TX|4853/2;3949/2;3184/2;897/2|
00000000|MMI|18.15|Diastole|C0012000|[clna]|["Diastolic"-tx-11-"diastolic"-adj-0]|TX|3426/9|G09.330.190.541.295;G11.427.590.540.554.250;G11.427.590.540.570.295
00000000|MMI|18.15|Docusate Sodium|C0243237|[orch,phsu]|["DOCUSATE SODIUM"-tx-2-"DOCUSATE SODIUM"-noun-0]|TX|684/15|D02.241.081.337.759.249
00000000|MMI|18.15|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-2-"FUROSEMIDE"-noun-0]|TX|817/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|18.15|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-12-"NAD"-noun-0]|TX|3930/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|17.64|Edema|C0013604|[fndg]|["OEDEMA"-tx-17-"edema"-noun-1,"OEDEMA"-tx-2-"edema"-noun-0]|TX|4021/5;938/5|C23.888.277
00000000|MMI|17.56|Disease|C0012634|[dsyn]|["condition"-tx-33-"CONDITION"-noun-0,"condition"-tx-5-"Conditions"-noun-0]|TX|5462/9;2695/10|C23.550.288
00000000|MMI|17.42|Kidney|C0022646|[bpoc]|["Renal"-tx-29-"renal"-adj-0,"Renal"-tx-28-"Renal"-adj-0]|TX|5110/5;4877/5|A05.810.453
00000000|MMI|17.06|Beds|C0004916|[mnob]|["Bed"-tx-6-"bed"-noun-0]|TX|[3198/3],[3232/3]|E07.325.220
00000000|MMI|17.04|Nonprofit Organizations|C0029247|[orgt]|["NPO"-tx-3-"NPO"-noun-0]|TX|[1194/3],[1885/3]|N03.540.630
00000000|MMI|16.99|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-3-"TAB"-noun-0,"TAB"-tx-2-"TAB"-noun-0]|TX|1106/3;441/3|D26.255.830
00000000|MMI|16.81|Giant Cell Arteritis|C0039483|[dsyn]|["POLYMYALGIA RHEUMATICA"-tx-21-"Polymyalgia rheumatica"-noun-0]|TX|4290/22|C10.114.875.700;C10.228.140.300.850.500;C14.907.253.946.700;C14.907.940.090.530;C14.907.940.907.700;C17.800.862.252;C20.111.258.962.800
00000000|MMI|16.78|Colace|C0282139|[orch,phsu]|["Colace"-tx-2-"COLACE"-noun-0]|TX|675/6|D02.241.081.337.759.249
00000000|MMI|16.77|Esomeprazole|C0937846|[orch,phsu]|["ESOMEPRAZOLE"-tx-2-"ESOMEPRAZOLE"-noun-0]|TX|716/12|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|16.76|Kidney Failure, Acute|C0022660|[dsyn]|["ACUTE RENAL FAILURE"-tx-28-"acute renal failure"-noun-0]|TX|4931/19|C12.777.419.780.050;C13.351.968.419.780.050
00000000|MMI|16.73|Mealtimes|C0587119|[tmco]|["Time, Meal"-tx-3-"mealtime"-noun-0]|TX|1794/8|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|16.72|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|225/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|16.67|Maine (geographic location)|C0024497|[geoa]|["Maine"-tx-1-"Maine"-noun-0]|TX|127/5|Z01.107.567.875.550.500
00000000|MMI|16.66|Lorazepam|C0024002|[orch,phsu]|["LORAZEPAM"-tx-12-"Lorazepam"-noun-0]|TX|3839/9|D03.438.079.080.070.450
00000000|MMI|16.65|Mitomycin|C0002475|[antb,orch]|["MMC"-tx-5-"MMC"-noun-0]|TX|2487/3|D02.806.400.249.350;D03.383.097.500.350;D03.438.473.412.249.350
00000000|MMI|16.51|Negation|C1518422|[ftcn]|["Not"-tx-28-"not"-adv-0,"Non"-tx-19-"non"-adj-0,"Not"-tx-6-"not"-adv-0,"Not"-tx-5-"NOT"-adv-0,"Not"-tx-3-"NOT"-adv-0]|TX|5070/3;4055/3;3238/3;2968/3;1337/3|
00000000|MMI|16.23|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-27-"pain"-noun-0,"Pain NOS"-tx-22-"pain"-noun-0,"Pain NOS"-tx-20-"Pain"-noun-0,"Pain NOS"-tx-3-"Pain"-noun-0]|TX|4721/4;[4329/4],[4351/4];4067/4;1121/4|
00000000|MMI|16.22|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-3-"Instruction"-noun-0,"instructions"-tx-3-"Instructions"-noun-0,"instructions"-tx-2-"Instructions"-noun-0]|TX|2237/11;[1168/12],[1859/12],[2074/12];870/12|
00000000|MMI|16.22|Instructions|C1442085|[idcn]|["Instructions"-tx-3-"Instructions"-noun-0,"instruction"-tx-3-"Instruction"-noun-0,"Instructions"-tx-2-"Instructions"-noun-0]|TX|[1168/12],[1859/12],[2074/12];2237/11;870/12|
00000000|MMI|15.75|Home environment|C0442519|[cnce]|["HOME"-tx-31-"home"-noun-0,"HOME"-tx-30-"home"-noun-0,"HOME"-tx-28-"home"-noun-0,"HOME"-tx-12-"Home"-noun-0,"HOME"-tx-2-"home"-noun-0]|TX|5306/4;5202/4;5012/4;3551/4;977/4|
00000000|MMI|15.73|Beginning|C0439659|[tmco]|["Start"-tx-26-"starting"-adj-0,"Start"-tx-24-"starting"-adj-0,"Start"-tx-3-"Starting"-adj-0,"Start"-tx-2-"Starting"-noun-0,"Start"-tx-2-"starts"-verb-0]|TX|4687/8;4562/8;2049/8;845/8;890/6|
00000000|MMI|15.42|Abdominal Pain|C0000737|[sosy]|["ABDOMINAL PAIN"-tx-7-"abdominal pain"-noun-1]|TX|3274/14|C10.597.617.044;C23.888.592.612.054;C23.888.821.030
00000000|MMI|15.42|Albuterol|C0001927|[orch,phsu]|["ALBUTEROL"-tx-2-"ALBUTEROL"-noun-0]|TX|463/9|D02.033.100.291.057;D02.092.063.291.057;D02.092.471.683.061
00000000|MMI|15.42|Dysuria|C0013428|[sosy]|["DYSURIA"-tx-7-"dysuria"-noun-1]|TX|3302/7|C23.888.942.343.274
00000000|MMI|15.42|Gout|C0018099|[dsyn]|["GOUT"-tx-5-"gout"-noun-0]|TX|3110/4|C05.550.114.423;C05.799.414;C16.320.565.798.368;C18.452.648.798.368
00000000|MMI|15.42|Hyperlipidemia|C0020473|[dsyn]|["Hyperlipidaemia, NOS"-tx-11-"Hyperlipidemia"-noun-0]|TX|3467/14|C18.452.584.500.500
00000000|MMI|15.42|Peptic Ulcer|C0030920|[dsyn]|["PEPTIC ULCER DISEASE"-tx-5-"peptic ulcer disease"-noun-0]|TX|2883/20|C06.405.469.275.800;C06.405.748.586
00000000|MMI|14.18|Calcium Carbonate|C0006681|[inch,phsu]|["CALCIUM CARBONATE"-tx-2-"CALCIUM CARBONATE"-noun-0]|TX|402/17|D01.146.275;D01.200.275.150.150;D01.578.200
00000000|MMI|14.08|Saudi Arabia|C0036243|[geoa]|["SA"-tx-1-"Sa"-noun-0]|TX|122/2|Z01.252.245.500.750
00000000|MMI|13.94|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-12-"Lipitor"-noun-0]|TX|3735/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|13.94|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-12-"Lisinopril"-noun-0]|TX|3698/10|D12.644.456.345.600
00000000|MMI|13.93|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-3-"Food/Drug Interaction"-noun-0]|TX|2215/21|G07.690.773.968.511
00000000|MMI|13.93|Acetaminophen|C0000970|[orch,phsu]|["APAP"-tx-3-"APAP"-noun-0]|TX|1089/4|D02.065.199.092.040
00000000|MMI|13.92|Asthma|C0004096|[dsyn]|["-- Asthma"-tx-5-"asthma"-noun-0]|TX|2793/6|C08.127.108;C08.381.495.108;C08.674.095;C20.543.480.680.095
00000000|MMI|13.91|Chronic pain|C0150055|[sosy]|["Chronic Pain"-tx-5-"chronic pain"-noun-0]|TX|3070/12|C10.597.617.196;C23.888.592.612.274
00000000|MMI|13.63|Generalized aches and pains|C0281856|[sosy]|["Generalized Pain"-tx-21-"Generalized pain"-noun-1,"Generalized Pain"-tx-5-"Generalized pain"-noun-0,"Generalized Pain"-tx-5-"generalized pain"-noun-0]|TX|4160/16;3024/16;3158/16|
00000000|MMI|12.82|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-3-"Instructions"-noun-0,"Instructions"-tx-2-"Instructions"-noun-0]|TX|[1168/12],[1859/12],[2074/12];870/12|
00000000|MMI|12.74|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-34-"Dr"-noun-0,"DR"-tx-33-"dr"-noun-0,"DR"-tx-24-"Dr"-noun-0,"DR"-tx-4-"Dr"-noun-0]|TX|5524/2;5501/2;4652/2;2472/2|
00000000|MMI|12.74|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-34-"Dr"-noun-0,"DR"-tx-33-"dr"-noun-0,"DR"-tx-24-"Dr"-noun-0,"DR"-tx-4-"Dr"-noun-0]|TX|5524/2;5501/2;4652/2;2472/2|
00000000|MMI|12.74|Doctor - Title|C2348314|[cnce]|["Dr."-tx-34-"Dr"-noun-0,"Dr."-tx-33-"dr"-noun-0,"Dr."-tx-24-"Dr"-noun-0,"Dr."-tx-4-"Dr"-noun-0]|TX|5524/2;5501/2;4652/2;2472/2|
00000000|MMI|12.73|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-3-"dose"-noun-0,"Dose number"-tx-3-"Number Doses"-noun-0,"Dose #"-tx-2-"dose"-noun-0]|TX|[1186/4],[1877/4];2103/6,2113/5;982/4|
00000000|MMI|12.69|Christmas Island|C0006888|[geoa]|["CXR"-tx-21-"CXR"-noun-0]|TX|4101/3|Z01.639.100;Z01.678.100.373
00000000|MMI|12.69|Degenerative polyarthritis|C0029408|[dsyn]|["OA"-tx-5-"OA"-noun-0]|TX|3090/2|C05.550.114.606;C05.799.613
00000000|MMI|12.69|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-31-"Diabetes Mellitus"-noun-0]|TX|5262/17|C18.452.394.750;C19.246
00000000|MMI|12.69|Diarrhea|C0011991|[sosy]|["DIARRHOEA"-tx-7-"diarrhea"-noun-1]|TX|3291/8|C23.888.821.214
00000000|MMI|12.69|Fever|C0015967|[fndg]|["Fevers"-tx-32-"fevers"-noun-0]|TX|5402/6|C23.888.119.344
00000000|MMI|12.69|Hospitalization|C0019993|[hlca]|["hospitalisation"-tx-28-"hospitalization"-noun-0]|TX|4895/15|E02.760.400;N02.421.585.400
00000000|MMI|12.69|Rales|C0034642|[sosy]|["Crackles"-tx-14-"crackles"-verb-0]|TX|3976/8|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|12.69|Rheumatology specialty|C0035452|[bmod]|["Rheumatology"-tx-24-"rheumatology"-noun-0]|TX|4509/12|H02.403.429.730
00000000|MMI|12.69|gabapentin|C0060926|[orch,phsu]|["GABAPENTIN"-tx-3-"GABAPENTIN"-noun-0]|TX|1011/10|x.x.x.x
00000000|MMI|12.57|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-37-"DISCHARGE"-noun-0,"Discharge"-tx-33-"DISCHARGE"-noun-0,"Discharge"-tx-5-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5638/9;5452/9;2597/9;39/9|
00000000|MMI|12.57|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-37-"DISCHARGE"-noun-0,"Discharge"-tx-33-"DISCHARGE"-noun-0,"Discharge"-tx-5-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5638/9;5452/9;2597/9;39/9|
00000000|MMI|12.48|Depressed mood|C0344315|[fndg]|["depression"-tx-30-"Depression"-noun-0,"depression"-tx-11-"Depression"-noun-0,"depression"-tx-5-"depression"-noun-0,"depression"-tx-3-"depression"-noun-0]|TX|5165/10;3515/10;2808/10;2092/10|
00000000|MMI|12.48|Depression Scale (BASC-2)|C4049644|[inpr]|["Depression"-tx-30-"Depression"-noun-0,"Depression"-tx-11-"Depression"-noun-0,"Depression"-tx-5-"depression"-noun-0,"Depression"-tx-3-"depression"-noun-0]|TX|5165/10;3515/10;2808/10;2092/10|
00000000|MMI|12.48|Depression motion|C0460137|[ftcn]|["Depression"-tx-30-"Depression"-noun-0,"Depression"-tx-11-"Depression"-noun-0,"Depression"-tx-5-"depression"-noun-0,"Depression"-tx-3-"depression"-noun-0]|TX|5165/10;3515/10;2808/10;2092/10|
00000000|MMI|12.23|Bedtime (qualifier value)|C0521112|[tmco]|["Bedtime"-tx-4-"BEDTIME"-noun-0,"Bedtime"-tx-3-"BEDTIME"-noun-0,"Bedtime"-tx-2-"BEDTIME"-noun-0]|TX|2318/7;[1851/7],[2207/7];558/7|
00000000|MMI|11.83|Inhaler|C0021461|[medd]|["INHALER"-tx-3-"INHALER"-noun-0]|TX|[1902/7],[1924/7]|E07.605
00000000|MMI|11.34|Suriname|C0038944|[geoa]|["NS"-tx-7-"NS"-noun-0]|TX|3269/2|Z01.107.757.833
00000000|MMI|11.33|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-33-"PLAN"-noun-0]|TX|5486/4|C10.228.140.744
00000000|MMI|11.32|Rheumatoid Arthritis|C0003873|[dsyn]|["RA - Rheumatoid arthritis"-tx-5-"ra rheumatoid arthritis"-noun-0]|TX|2819/2,2824/20|C05.550.114.154;C05.799.114;C17.300.775.099;C20.111.199
00000000|MMI|11.31|Diet|C0012155|[food]|["Diet"-tx-4-"DIET"-noun-0]|TX|2339/4|G07.203.650.240
00000000|MMI|11.29|Rabbi|C0684010|[prog]|["R."-tx-5-"R"-noun-0]|TX|2977/1|M01.526.799.500
00000000|MMI|11.26|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|225/3|E04.157.310;E04.950.300.299
00000000|MMI|11.21|Calcium|C0006675|[bacs,elii,phsu]|["CALCIUM"-tx-26-"calcium"-noun-0]|TX|4696/7|D01.268.552.100;D01.552.539.288;D23.119.100;x.x.x.x
00000000|MMI|11.21|Niue|C0028219|[geoa]|["NE"-tx-1-"Ne"-noun-0]|TX|116/2|Z01.639.760.815
00000000|MMI|11.19|elongation factor DmS-II|C0378717|[aapp]|["dm ii"-tx-5-"DM II"-noun-0]|TX|2782/2,2790/2|x.x.x.x
00000000|MMI|11.19|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-9-"baseline"-noun-0]|TX|3389/8|x.x.x.x
00000000|MMI|11.18|Wheezing|C0043144|[sosy]|["WHEEZING"-tx-2-"Wheezing"-noun-0]|TX|522/8|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|11.18|Palpation|C0030247|[diap]|["PALPATION"-tx-20-"palpation"-noun-0]|TX|4075/9|E01.370.600.600
00000000|MMI|10.17|Order (action)|C1705178|[acty]|["Order"-tx-37-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5648/6;229/5;49/6|
00000000|MMI|10.17|Order (arrangement)|C1705176|[qlco]|["Order"-tx-37-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5648/6;229/5;49/6|
00000000|MMI|10.17|Order (document)|C1705175|[inpr]|["Order"-tx-37-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5648/6;229/5;49/6|
00000000|MMI|10.17|Order (taxonomic)|C1705177|[clas]|["Order"-tx-37-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5648/6;229/5;49/6|
00000000|MMI|10.17|Permutation|C1882348|[qlco]|["Order"-tx-37-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5648/6;229/5;49/6|
00000000|MMI|10.17|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-37-"ORDERS"-verb-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|5648/6;229/5;49/6|
00000000|MMI|9.95|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-5-"ALLERGY"-noun-0]|TX|2544/7|H02.403.044
00000000|MMI|9.95|Chills|C0085593|[sosy]|["CHILLS"-tx-32-"chills"-noun-0]|TX|5411/6|C23.888.208
00000000|MMI|9.95|Complication Aspects|C1171258|[patf]|["complications"-tx-5-"Complications"-noun-0]|TX|2721/13|x.x.x
00000000|MMI|9.95|Cor pulmonale|C0034072|[dsyn]|["COR PULMONALE"-tx-11-"Cor pulmonale"-noun-0]|TX|3440/13|C14.280.832
00000000|MMI|9.95|Heart murmur|C0018808|[fndg]|["MURMUR"-tx-15-"murmur"-noun-1]|TX|3996/6|C23.888.447
00000000|MMI|9.95|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-11-"HTN"-noun-0]|TX|3461/3|C14.907.489
00000000|MMI|9.95|Methods aspects|C0025664|[inpr]|["procedures"-tx-5-"PROCEDURES"-noun-0]|TX|2921/10|x.x.x
00000000|MMI|9.55|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-12-"QHS"-noun-0,"qHS"-tx-12-"qhs"-noun-0]|TX|3630/3;[3746/3],[3818/3]|
00000000|MMI|9.54|suggestion|C1705535|[idcn]|["Suggest"-tx-27-"suggested"-verb-0,"Suggest"-tx-26-"suggested"-verb-0,"Suggest"-tx-24-"suggested"-adj-0]|TX|4794/9;4677/9;4552/9|
00000000|MMI|9.50|Increase|C0442805|[ftcn]|["Increased"-tx-5-"increased"-verb-0,"Increase"-tx-2-"increase"-verb-0,"Increased"-tx-2-"increased"-adj-0]|TX|3148/9;948/8;928/9|
00000000|MMI|9.46|Dosage|C0178602|[qnco]|["DOSE"-tx-3-"dose"-noun-0,"DOSE"-tx-2-"dose"-noun-0]|TX|[1186/4],[1877/4];982/4|
00000000|MMI|9.46|Unit dose|C0869039|[qnco]|["Dose"-tx-3-"dose"-noun-0,"Dose"-tx-2-"dose"-noun-0]|TX|[1186/4],[1877/4];982/4|
00000000|MMI|9.39|Insulin Drug Class|C3714501|[horm,phsu]|["INSULIN"-tx-31-"insulin"-noun-0,"INSULIN"-tx-3-"insulin"-noun-0]|TX|5311/7;[1383/7],[1803/7]|
00000000|MMI|9.39|Insulin [EPC]|C1579433|[phsu]|["Insulin"-tx-31-"insulin"-noun-0,"Insulin"-tx-3-"insulin"-noun-0]|TX|5311/7;[1383/7],[1803/7]|
00000000|MMI|9.39|Recombinant Insulin|C1533581|[aapp,horm,phsu]|["INSULIN"-tx-31-"insulin"-noun-0,"INSULIN"-tx-3-"insulin"-noun-0]|TX|5311/7;[1383/7],[1803/7]|
00000000|MMI|9.26|mg/mg|C1319635|[qnco]|["mg/mg"-tx-3-"MG MG"-noun-0,"mg/mg"-tx-2-"MG MG"-noun-0]|TX|2174/2,2201/2;[507/2,552/2],[706/2,732/2]|
00000000|MMI|9.23|1-2|C3843716|[fndg]|["1-2"-tx-3-"1-2"-integer-0,"1-2"-tx-3-"1/2"-fraction-0]|TX|1102/3;[1182/3],[1873/3]|
00000000|MMI|9.23|1/2|C0580272|[inpr]|["1/2"-tx-3-"1-2"-integer-0,"1/2"-tx-3-"1/2"-fraction-0]|TX|1102/3;[1182/3],[1873/3]|
00000000|MMI|9.23|Phase I/II Trial|C1519043|[resa]|["1-2"-tx-3-"1-2"-integer-0,"1-2"-tx-3-"1/2"-fraction-0]|TX|1102/3;[1182/3],[1873/3]|
00000000|MMI|9.11|1+|C3816745|[fndg]|["1+"-tx-3-"1"-integer-0,"1+"-tx-2-"1"-integer-0]|TX|1472/1;[439/1],[794/1]|
00000000|MMI|9.11|1+ Score|C2827734|[qnco]|["1+"-tx-3-"1"-integer-0,"1+"-tx-2-"1"-integer-0]|TX|1472/1;[439/1],[794/1]|
00000000|MMI|9.11|1+ Score, WHO|C2981698|[clas]|["1+"-tx-3-"1"-integer-0,"1+"-tx-2-"1"-integer-0]|TX|1472/1;[439/1],[794/1]|
00000000|MMI|9.10|0%|C3842591|[fndg]|["0%"-tx-12-"0"-integer-0,"0%"-tx-3-"0"-integer-0,"0%"-tx-2-"0"-fraction-0]|TX|3849/1;1420/1;503/1|
00000000|MMI|9.10|ASAH1 gene|C1412573|[gngm]|["AC"-tx-12-"AC"-noun-0,"AC"-tx-3-"AC"-noun-0]|TX|3648/2;[1165/2],[1261/2]|
00000000|MMI|9.10|ASAH1 wt Allele|C3539770|[gngm]|["AC"-tx-12-"AC"-noun-0,"AC"-tx-3-"AC"-noun-0]|TX|3648/2;[1165/2],[1261/2]|
00000000|MMI|9.07|20%|C3842589|[fndg]|["20%"-tx-12-"20"-integer-0,"20%"-tx-5-"20"-integer-0,"20%"-tx-3-"20"-integer-0]|TX|3709/2;3058/2;2198/2|
00000000|MMI|9.02|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-5-"DIAGNOSIS"-noun-0]|TX|[2563/9],[2685/9]|E01
00000000|MMI|9.02|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-5-"DIAGNOSIS"-noun-0]|TX|[2563/9],[2685/9]|
00000000|MMI|9.02|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-36-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|5591/3;304/3|
00000000|MMI|9.02|Hold (action)|C1948035|[acty]|["Hold"-tx-3-"HOLD"-verb-0,"Hold"-tx-2-"HOLD"-verb-0]|TX|1038/4;604/4|
00000000|MMI|9.02|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-3-"HOLD"-verb-0,"Hold"-tx-2-"HOLD"-verb-0]|TX|1038/4;604/4|
00000000|MMI|9.02|Insulin, Aspart, Human|C0123677|[aapp,horm,phsu]|["INSULIN ASPART"-tx-3-"INSULIN ASPART"-noun-0]|TX|[1136/14],[1208/14]|
00000000|MMI|9.02|Obtain|C1301820|[ftcn]|["Obtained"-tx-24-"obtained"-verb-0,"Obtained"-tx-22-"obtained"-verb-0]|TX|4539/8;4368/8|
00000000|MMI|9.02|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-5-"scheduled"-verb-0,"Scheduled"-tx-4-"scheduled"-verb-0]|TX|2532/9;2460/9|
00000000|MMI|9.02|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-5-"scheduled"-verb-0,"Scheduled"-tx-4-"scheduled"-verb-0]|TX|2532/9;2460/9|
00000000|MMI|9.02|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-5-"scheduled"-verb-0,"Scheduled"-tx-4-"scheduled"-verb-0]|TX|2532/9;2460/9|
00000000|MMI|9.02|Shortness of breath:-:Point in time:^Patient:-|C2707305|[clna]|["Shortness of breath"-tx-32-"shortness of breath"-noun-0,"Shortness of breath"-tx-2-"shortness of breath"-noun-0]|TX|5430/19;905/19|
00000000|MMI|9.02|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-3-"HOLD"-verb-0,"hold"-tx-2-"HOLD"-verb-0]|TX|1038/4;604/4|
00000000|MMI|9.02|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-37-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|5648/6;49/6|
00000000|MMI|8.72|Adjustment Disorders|C0001546|[mobd]|["ADJUSTMENT DISORDER"-tx-11-"Adjustment Disorder"-noun-0]|TX|3526/19|F03.950.500
00000000|MMI|8.58|Appointments|C0003629|[idcn]|["Appointment"-tx-4-"APPOINTMENT"-noun-0]|TX|2414/11|N04.452.095
00000000|MMI|8.58|Diet therapy|C0012159|[hlca]|["Diet"-tx-4-"DIET"-noun-0]|TX|2339/4|E02.642.249
00000000|MMI|8.53|objective (goal)|C0018017|[inpr]|["Goal"-tx-2-"goal"-noun-0]|TX|960/4|F01.658.500
00000000|MMI|8.50|Abdomen|C0000726|[blor]|["abd"-tx-16-"Abd"-adj-0]|TX|4005/3|A01.923.047
00000000|MMI|8.48|Calcium, Dietary|C0006726|[inch]|["Calcium"-tx-26-"calcium"-noun-0]|TX|4696/7|D01.146.315
00000000|MMI|8.48|Neurology speciality|C0027855|[bmod]|["NEURO"-tx-19-"Neuro"-adj-0]|TX|4049/5|H02.403.600
00000000|MMI|8.48|Rehabilitation aspects|C0034992|[ftcn]|["Rehabilitation"-tx-2-"Rehabilitation"-noun-0]|TX|345/14|x.x.x
00000000|MMI|8.45|Arthritis|C0003864|[dsyn]|["ARTHRITIS"-tx-5-"arthritis"-noun-0]|TX|2772/9|C05.550.114
00000000|MMI|8.45|Pneumonia|C0032285|[dsyn]|["PNEUMONIA"-tx-5-"pneumonia"-noun-0]|TX|2762/9|C08.381.677;C08.730.610
00000000|MMI|8.45|Anxiety|C0003467|[mobd]|["-- Anxiety"-tx-3-"Anxiety"-noun-0]|TX|1977/7|F01.470.132
00000000|MMI|7.22|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-5-"ALLERGY"-noun-0]|TX|2544/7|C20.543
00000000|MMI|7.22|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-5-"ALLERGY"-noun-0]|TX|2544/7|C20.543
00000000|MMI|7.22|Infection|C3714514|[patf]|["Infections"-tx-5-"Infections"-noun-0]|TX|2708/10|C01.539
00000000|MMI|6.78|sliding scale|C2937251|[topp]|["sliding scale"-tx-3-"Sliding Scale"-noun-0,"sliding scale"-tx-3-"sliding scale"-noun-0]|TX|1225/13;1367/13|
00000000|MMI|6.66|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-17-"edema"-noun-0,"Edema"-tx-2-"edema"-noun-0]|TX|4021/5;938/5|
00000000|MMI|6.66|Hospital admission|C0184666|[hlca]|["Admission"-tx-5-"Admission"-noun-0,"Admit"-tx-5-"ADMIT"-verb-0]|TX|2654/9;2557/5|
00000000|MMI|6.66|Neurontin|C0678176|[orch,phsu]|["Neurontin"-tx-22-"neurontin"-noun-0,"Neurontin"-tx-3-"NEURONTIN"-noun-0]|TX|4432/9;999/9|
00000000|MMI|6.66|Vicodin|C0483514|[orch,phsu]|["Vicodin"-tx-22-"vicodin"-noun-0,"Vicodin"-tx-3-"VICODIN"-noun-0]|TX|4399/7;1060/7|
00000000|MMI|6.59|Physical therapy (field)|C0699718|[bmod]|["physical therapy"-tx-27-"physical therapy"-noun-0,"PT"-tx-2-"pt"-noun-0]|TX|4773/16;887/2|
00000000|MMI|6.58|Condition|C0348080|[qlco]|["Condition"-tx-33-"CONDITION"-noun-0,"Condition"-tx-5-"Conditions"-noun-0]|TX|5462/9;2695/10|
00000000|MMI|6.58|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-33-"CONDITION"-noun-0,"Condition"-tx-5-"Conditions"-noun-0]|TX|5462/9;2695/10|
00000000|MMI|6.58|Logical Condition|C1705253|[cnce]|["Condition"-tx-33-"CONDITION"-noun-0,"Condition"-tx-5-"Conditions"-noun-0]|TX|5462/9;2695/10|
00000000|MMI|6.52|HORNS IN SHEEP|C1832110|[fndg]|["HO"-tx-3-"HO"-noun-0]|TX|[1282/2],[1708/2]|
00000000|MMI|6.52|Healthcare Encounters Domain|C3889614|[inpr]|["HO"-tx-3-"HO"-noun-0]|TX|[1282/2],[1708/2]|
00000000|MMI|6.44|Geographic state|C1301808|[geoa]|["State"-tx-29-"state"-noun-0,"stated"-tx-28-"stated"-verb-0]|TX|5116/5;5055/6|
00000000|MMI|6.44|State|C1442792|[ftcn]|["State"-tx-29-"state"-noun-0,"Stated"-tx-28-"stated"-verb-0]|TX|5116/5;5055/6|
00000000|MMI|6.40|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-2-"lt"-noun-0]|TX|[617/2],[629/2]|
00000000|MMI|6.40|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-2-"lt"-noun-0]|TX|[617/2],[629/2]|
00000000|MMI|6.37|Increased|C0205217|[qnco]|["Increased"-tx-5-"increased"-verb-0,"Increased"-tx-2-"increased"-adj-0]|TX|3148/9;928/9|
00000000|MMI|6.34|Inhaler Dosing Unit|C1881212|[qnco]|["INHALER"-tx-3-"INHALER"-noun-0]|TX|[1902/7],[1924/7]|
00000000|MMI|6.33|Axial R|C3538806|[spco]|["Ra"-tx-12-"RA"-adj-0,"Ra"-tx-5-"RA"-noun-0]|TX|3896/2;3085/2|
00000000|MMI|6.33|Right arm|C4048756|[bpoc]|["RA"-tx-12-"RA"-adj-0,"RA"-tx-5-"RA"-noun-0]|TX|3896/2;3085/2|
00000000|MMI|6.33|Topamax|C0723778|[orch,phsu]|["Topamax"-tx-22-"topamax"-noun-0,"Topamax"-tx-12-"Topamax"-noun-0]|TX|4454/7;3599/7|
00000000|MMI|6.30|DuoNeb|C0939692|[orch,phsu]|["DuoNeb"-tx-12-"Duoneb"-noun-0,"DuoNeb"-tx-2-"DUONEB"-noun-0]|TX|3674/6;454/6|
00000000|MMI|6.29|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-3-"Call"-noun-0,"Call"-tx-3-"Call"-verb-0]|TX|[1277/4],[1703/4];[1277/4],[1703/4]|
00000000|MMI|6.29|Decision|C0679006|[menp]|["Call"-tx-3-"Call"-noun-0,"Call"-tx-3-"Call"-verb-0]|TX|[1277/4],[1703/4];[1277/4],[1703/4]|
00000000|MMI|6.29|Hospital course|C0489547|[fndg]|["Hospital course"-tx-21-"Hospital course"-noun-1,"Hospital course"-tx-5-"HOSPITAL COURSE"-noun-1]|TX|4143/15;3003/15|
00000000|MMI|6.29|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-21-"Hospital course"-noun-0,"Hospital course"-tx-5-"HOSPITAL COURSE"-noun-0]|TX|4143/15;3003/15|
00000000|MMI|6.28|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-11-"DM"-noun-0,"DM"-tx-5-"DM"-noun-0]|TX|3456/2;2782/2|
00000000|MMI|6.28|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-11-"Obesity"-noun-0,"Obesity"-tx-5-"obesity"-noun-0]|TX|3484/7;2800/7|
00000000|MMI|6.28|Summary (document)|C1706244|[inpr]|["Summary"-tx-35-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|5548/7;254/7|
00000000|MMI|6.28|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-35-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|5548/7;254/7|
00000000|MMI|6.24|Rheumatologist|C0334889|[prog]|["Rheumatologist"-tx-24-"rheumatologist"-noun-0,"Rheumatology"-tx-24-"rheumatology"-noun-0]|TX|4637/14;4509/12|
00000000|MMI|6.19|+5|C0728893|[qnco]|["+5"-tx-3-"5"-integer-0,"+5"-tx-1-"5"-fraction-0]|TX|1680/1;16/1|
00000000|MMI|6.19|>5|C0439084|[qnco]|[">5"-tx-3-"5"-integer-0,">5"-tx-1-"5"-fraction-0]|TX|1680/1;16/1|
00000000|MMI|6.18|Continuous|C0549178|[idcn]|["Continued"-tx-31-"continued"-verb-0,"Continued"-tx-30-"continued"-verb-0]|TX|5289/9;5185/9|
00000000|MMI|6.18|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-31-"regimen"-noun-0,"regimen"-tx-30-"regimen"-noun-0]|TX|5319/7;5207/7|
00000000|MMI|6.16|50%|C3842586|[fndg]|["50%"-tx-2-"50"-fraction-0,"50%"-tx-2-"50"-integer-0]|TX|[632/2],[760/2];[632/2],[760/2]|
00000000|MMI|6.16|<50|C3843766|[fndg]|["<50"-tx-2-"50"-fraction-0,"<50"-tx-2-"50"-integer-0]|TX|[632/2],[760/2];[632/2],[760/2]|
00000000|MMI|6.13|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-37-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|5621/2;191/2|
00000000|MMI|6.13|/40|C0439509|[tmco]|["/40"-tx-12-"40"-integer-0,"/40"-tx-2-"40"-integer-0]|TX|3761/2;729/2|
00000000|MMI|6.13|40%|C3842587|[qnco]|["40%"-tx-12-"40"-integer-0,"40%"-tx-2-"40"-integer-0]|TX|3761/2;729/2|
00000000|MMI|6.12|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-24-"follow up"-adj-0,"FOLLOW-UP"-tx-4-"FOLLOW UP"-adj-0]|TX|4618/9;2404/9|
00000000|MMI|6.12|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-24-"follow up"-adj-0,"Follow-Up"-tx-4-"FOLLOW UP"-adj-0]|TX|4618/9;2404/9|
00000000|MMI|6.12|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-24-"follow up"-adj-0,"Follow-up"-tx-4-"FOLLOW UP"-adj-0]|TX|4618/9;2404/9|
00000000|MMI|6.12|follow-up|C1522577|[hlca]|["Follow Up"-tx-24-"follow up"-adj-0,"Follow Up"-tx-4-"FOLLOW UP"-adj-0]|TX|4618/9;2404/9|
00000000|MMI|6.09|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-5-"RESUME"-noun-0,"Resume"-tx-4-"Resume"-noun-0]|TX|2993/6;2380/6|
00000000|MMI|6.09|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-5-"RESUME"-noun-0,"Resume"-tx-4-"Resume"-noun-0]|TX|2993/6;2380/6|
00000000|MMI|6.09|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-5-"RESUME"-noun-0,"resume"-tx-4-"Resume"-noun-0]|TX|2993/6;2380/6|
00000000|MMI|6.08|Due to|C0678226|[ftcn]|["Due To"-tx-29-"due to"-prep-0,"Due To"-tx-28-"due to"-prep-0]|TX|5097/6;4951/6|
00000000|MMI|6.07|Code|C0805701|[inpr]|["CODE"-tx-2-"CODE"-noun-0,"CODE"-tx-2-"code"-noun-0]|TX|309/4;327/4|
00000000|MMI|6.07|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-2-"CODE"-noun-0,"Code"-tx-2-"code"-noun-0]|TX|309/4;327/4|
00000000|MMI|6.06|NPO - Nothing by mouth|C0419179|[topp]|["NPO"-tx-3-"NPO"-noun-0]|TX|[1194/3],[1885/3]|
00000000|MMI|6.02|+2|C0740116|[qnco]|["+2"-tx-3-"2"-integer-0]|TX|[1524/1],[1934/1]|
00000000|MMI|6.02|2+|C3833492|[fndg]|["2+"-tx-3-"2"-integer-0]|TX|[1524/1],[1934/1]|
00000000|MMI|6.02|2+ Score|C2827735|[qnco]|["2+"-tx-3-"2"-integer-0]|TX|[1524/1],[1934/1]|
00000000|MMI|6.02|2+ Score, WHO|C2981700|[clas]|["2+"-tx-3-"2"-integer-0]|TX|[1524/1],[1934/1]|
00000000|MMI|6.02|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-3-"3"-integer-0,"3+"-tx-2-"3"-fraction-0]|TX|1576/1;501/1|
00000000|MMI|6.02|3+ Score|C2827736|[qnco]|["3+"-tx-3-"3"-integer-0,"3+"-tx-2-"3"-fraction-0]|TX|1576/1;501/1|
00000000|MMI|6.02|3+ Score, WHO|C2981702|[clas]|["3+"-tx-3-"3"-integer-0,"3+"-tx-2-"3"-fraction-0]|TX|1576/1;501/1|
00000000|MMI|6.02|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-3-"3"-integer-0,"<3"-tx-2-"3"-fraction-0]|TX|1576/1;501/1|
00000000|MMI|6.01|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-3-"TAB"-noun-0,"Tab"-tx-2-"TAB"-noun-0]|TX|1106/3;441/3|
00000000|MMI|6.01|Picofarad (unit of measure)|C1882376|[qnco]|["Puff"-tx-3-"PUFF"-noun-0,"Puff"-tx-2-"PUFF"-noun-0]|TX|1936/4;796/4|
00000000|MMI|6.01|Puff unit dose|C1533107|[qnco]|["PUFF"-tx-3-"PUFF"-noun-0,"PUFF"-tx-2-"PUFF"-noun-0]|TX|1936/4;796/4|
00000000|MMI|6.00|Every six hours|C0585325|[tmco]|["Q6H"-tx-3-"Q6H"-noun-0]|TX|[1113/3],[1969/3]|
00000000|MMI|6.00|Insomnia Adverse Event|C1963237|[fndg]|["Insomnia"-tx-4-"Insomnia"-noun-0,"Insomnia"-tx-2-"Insomnia"-noun-0]|TX|2330/8;570/8|
00000000|MMI|6.00|60%|C3842585|[fndg]|["60%"-tx-3-"60"-integer-0]|TX|[1301/2],[1839/2]|
00000000|MMI|5.92|Nebulizers|C0027524|[medd]|["Nebuliser"-tx-2-"NEBULIZER"-noun-0]|TX|489/9|E07.605
00000000|MMI|5.89|Physical therapy|C0949766|[topp]|["Physical Therapy"-tx-27-"physical therapy"-noun-0]|TX|4773/16|E02.779
00000000|MMI|5.84|Feces|C0015733|[bdsu]|["stooling"-tx-6-"stooling"-noun-0]|TX|3220/8|A12.459
00000000|MMI|5.84|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-3-"Instruction"-noun-0]|TX|2237/11|I02.903
00000000|MMI|5.81|Time|C0040223|[tmco]|["TIME"-tx-3-"time"-noun-0]|TX|1761/4|G01.910
00000000|MMI|5.74|pH|C4048290|[qnco]|["pH"-tx-1-"Ph"-noun-0]|TX|119/2|G02.300
00000000|MMI|5.72|Anxiety Disorders|C0003469|[mobd]|["Anxiety"-tx-3-"Anxiety"-noun-0]|TX|1977/7|F03.080
00000000|MMI|4.49|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-5-"OPERATIONS"-noun-0]|TX|2906/10|
00000000|MMI|4.49|Additional comments|C1830770|[fndg]|["Additional comments"-tx-32-"ADDITIONAL COMMENTS"-noun-0]|TX|5352/19|
00000000|MMI|4.49|Administer|C1621583|[ftcn]|["Administer"-tx-3-"Administer"-verb-0]|TX|1341/10|
00000000|MMI|4.49|Affecting|C0392760|[ftcn]|["Affecting"-tx-5-"affecting"-verb-0]|TX|2737/9|
00000000|MMI|4.49|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-5-"ALLERGY"-noun-0]|TX|2544/7|
00000000|MMI|4.49|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-5-"ALLERGY"-noun-0]|TX|2544/7|
00000000|MMI|4.49|Approximate|C0332232|[qlco]|["Approximate"-tx-3-"approximate"-adj-0]|TX|2130/11|
00000000|MMI|4.49|Assessed|C1516048|[acty]|["Assess"-tx-13-"assess"-verb-0]|TX|3952/6|
00000000|MMI|4.49|Basilar Rales|C0240859|[fndg]|["Crackles"-tx-14-"crackles"-verb-0]|TX|3976/8|
00000000|MMI|4.49|Broken skin|C0150077|[fndg]|["Skin breakdown"-tx-18-"skin breakdown"-noun-1]|TX|4032/14|
00000000|MMI|4.49|C-Circle|C3538933|[celc]|["CC"-tx-5-"CC"-noun-0]|TX|3020/2|
00000000|MMI|4.49|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-11-"CAD"-noun-0]|TX|3414/3|
00000000|MMI|4.49|Changed status|C0443172|[qnco]|["changes"-tx-23-"changes"-noun-0]|TX|4470/7|
00000000|MMI|4.49|Changing|C0392747|[ftcn]|["changes"-tx-23-"changes"-noun-0]|TX|4470/7|
00000000|MMI|4.49|Chronic pulmonary heart disease|C0238074|[dsyn]|["Cor Pulmonale"-tx-11-"Cor pulmonale"-noun-0]|TX|3440/13|
00000000|MMI|4.49|Complication|C0009566|[patf]|["Complications"-tx-5-"Complications"-noun-0]|TX|2721/13|
00000000|MMI|4.49|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-11-"CHF"-noun-0]|TX|3420/3|
00000000|MMI|4.49|Deny (action)|C2700401|[acty]|["Deny"-tx-7-"Denies"-verb-0]|TX|3258/6|
00000000|MMI|4.49|Diarrhea Adverse Event|C1963091|[fndg]|["Diarrhea"-tx-7-"diarrhea"-noun-1]|TX|3291/8|
00000000|MMI|4.49|Difficult (qualifier value)|C0332218|[qlco]|["Difficult"-tx-13-"difficult"-adj-0]|TX|3939/9|
00000000|MMI|4.49|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.49|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.49|Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}|C1316572|[clna]|["Note"-tx-8-"NOTE"-noun-0]|TX|3345/4|
00000000|MMI|4.49|Fluticasone propionate|C0117996|[orch,phsu]|["FLUTICASONE PROPIONATE"-tx-2-"FLUTICASONE PROPIONATE"-noun-0]|TX|765/22|
00000000|MMI|4.49|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-3-"grapefruit"-noun-0]|TX|2255/10|
00000000|MMI|4.49|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-3-"grapefruit"-noun-0]|TX|2255/10|
00000000|MMI|4.49|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-3-"grapefruit"-noun-0]|TX|2255/10|
00000000|MMI|4.49|Greatly|C3840786|[fndg]|["Greatly"-tx-5-"greatly"-adv-0]|TX|3140/7|
00000000|MMI|4.49|H/O: duodenal ulcer|C0559164|[fndg]|["H/O: duodenal ulcer"-tx-11-"H/o duodenal ulcer"-noun-0]|TX|3494/18|
00000000|MMI|4.49|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-5-"OPERATIONS"-noun-0]|TX|2906/10|
00000000|MMI|4.49|Has difficulty doing (qualifier value)|C1299586|[fndg]|["Difficult"-tx-13-"difficult"-adj-0]|TX|3939/9|
00000000|MMI|4.49|Impaired skin integrity|C4048181|[fndg]|["skin breakdown"-tx-18-"skin breakdown"-noun-1]|TX|4032/14|
00000000|MMI|4.49|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-5-"PROCEDURES"-noun-0]|TX|2921/10|
00000000|MMI|4.49|Involvement with|C1314939|[ftcn]|["Affecting"-tx-5-"affecting"-verb-0]|TX|2737/9|
00000000|MMI|4.49|Note (document)|C1317574|[inpr]|["Note"-tx-8-"NOTE"-noun-0]|TX|3345/4|
00000000|MMI|4.49|OSTEOARTHRITIS SUSCEPTIBILITY 1|C3887876|[fndg]|["OA"-tx-5-"OA"-noun-0]|TX|3090/2|
00000000|MMI|4.49|Patient Outcome - Worsening|C1546960|[idcn]|["Worsening"-tx-32-"worsening"-verb-0]|TX|5420/9|
00000000|MMI|4.49|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-2-"pt"-noun-0]|TX|887/2|
00000000|MMI|4.49|Plain chest X-ray|C0039985|[diap]|["cxr"-tx-21-"CXR"-noun-0]|TX|4101/3|
00000000|MMI|4.49|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-5-"PROCEDURES"-noun-0]|TX|2921/10|
00000000|MMI|4.49|Recommendation|C0034866|[idcn]|["Recommended"-tx-22-"recommended"-verb-0]|TX|4381/11|
00000000|MMI|4.49|Requirement|C1514873|[ftcn]|["Required"-tx-3-"Required"-verb-0]|TX|2119/8|
00000000|MMI|4.49|Resolution|C2699488|[cnce]|["Resolved"-tx-29-"resolved"-verb-0]|TX|5126/8|
00000000|MMI|4.49|Resolved|C3714811|[fndg]|["Resolved"-tx-29-"resolved"-verb-0]|TX|5126/8|
00000000|MMI|4.49|Resolved License|C3897700|[ftcn]|["Resolved"-tx-29-"resolved"-verb-0]|TX|5126/8|
00000000|MMI|4.49|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-5-"ALLERGY"-noun-0]|TX|2544/7|
00000000|MMI|4.49|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-32-"return"-verb-0]|TX|5380/6|
00000000|MMI|4.49|S prime|C2603362|[clna]|["S'"-tx-4-"("-noun-0]|TX|2425/1|
00000000|MMI|4.49|Serum lipids high (finding)|C0428465|[fndg]|["Hyperlipidemia"-tx-11-"Hyperlipidemia"-noun-0]|TX|3467/14|
00000000|MMI|4.49|Skin Erosion|C3887524|[dsyn]|["Skin Breakdown"-tx-18-"skin breakdown"-noun-1]|TX|4032/14|
00000000|MMI|4.49|Supplement|C2348609|[ftcn]|["Supplemental"-tx-3-"supplemental"-adj-0]|TX|1352/12|
00000000|MMI|4.49|Symptoms|C1457887|[sosy]|["SYMPTOMS"-tx-21-"symptoms"-noun-0]|TX|4251/8|
00000000|MMI|4.49|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-21-"symptoms"-noun-0]|TX|4251/8|
00000000|MMI|4.49|TAC1 wt Allele|C1705924|[gngm]|["NKA"-tx-5-"NKA"-noun-0]|TX|2553/3|
00000000|MMI|4.49|Unable|C1299582|[fndg]|["Unable"-tx-6-"Unable"-adj-0]|TX|3177/6|
00000000|MMI|4.49|Use of|C1524063|[ftcn]|["Using"-tx-22-"using"-verb-0]|TX|4393/5|
00000000|MMI|4.49|Worse|C1457868|[fndg]|["Worsening"-tx-32-"worsening"-verb-0]|TX|5420/9|
00000000|MMI|4.49|Worsening pattern|C0332271|[qlco]|["Worsening"-tx-32-"worsening"-verb-0]|TX|5420/9|
00000000|MMI|4.49|buspirone hydrochloride|C0700444|[orch,phsu]|["buspirone hcl"-tx-2-"BUSPIRONE HCL"-noun-0]|TX|644/13|
00000000|MMI|4.49|per second|C0565930|[qnco]|["/s"-tx-4-"("-noun-0]|TX|2425/1|
00000000|MMI|4.49|physiologic resolution|C1514893|[patf]|["Resolved"-tx-29-"resolved"-verb-0]|TX|5126/8|
00000000|MMI|4.49|quetiapine|C0123091|[orch,phsu]|["QUETIAPINE"-tx-3-"QUETIAPINE"-noun-0]|TX|2020/10|
00000000|MMI|4.49|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-5-"TREATMENTS/PROCEDURES"-noun-0]|TX|2944/21|
00000000|MMI|3.44|Take|C1515187|[hlca]|["Take"-tx-28-"taking"-verb-0]|TX|5079/6|
00000000|MMI|3.28|exacerbation acute|C0743630|[fndg]|["acute exacerbation"-tx-22-"acute exacerbation"-noun-0]|TX|4323/5,4334/12|
00000000|MMI|3.25|10 - 12|C3843787|[fndg]|["10 - 12"-tx-37-"10 12"-fraction-0]|TX|5605/2,5615/2|
00000000|MMI|3.25|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-2-"DISCHARGE MEDICATIONS"-noun-0]|TX|360/21|
00000000|MMI|3.24|Domestic activities|C0441660|[dora]|["house activity"-tx-4-"House ACTIVITY"-noun-0]|TX|2345/5,2370/8|
00000000|MMI|3.22|Greater Than|C0439093|[qnco]|["Greater Than"-tx-3-"greater than"-adj-0]|TX|1720/12|
00000000|MMI|3.22|Less Than|C0439092|[qnco]|["Less Than"-tx-3-"less than"-adv-0]|TX|1313/9|
00000000|MMI|3.21|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-5-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2587/9,2607/9|
00000000|MMI|3.21|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-5-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2587/9,2607/9|
00000000|MMI|3.19|Admission activity|C0809949|[hlca]|["Admission"-tx-5-"Admission"-noun-0]|TX|2654/9|
00000000|MMI|3.19|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|267/9|
00000000|MMI|3.19|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|267/9|
00000000|MMI|3.19|Benign|C0205183|[qlco]|["BENIGN"-tx-16-"benign"-adj-0]|TX|4009/6|
00000000|MMI|3.19|Caltrate|C0719118|[inch,phsu]|["Caltrate"-tx-2-"CALTRATE"-noun-0]|TX|383/8|
00000000|MMI|3.19|Clipperton Island|C4050020|[geoa]|["CP"-tx-8-"CP"-noun-0]|TX|3366/2|
00000000|MMI|3.19|Control function|C2587213|[ftcn]|["Control"-tx-31-"control"-noun-0]|TX|5342/7|
00000000|MMI|3.19|Incontinent|C0231238|[ftcn]|["Incontinent"-tx-6-"incontinent"-adj-0]|TX|3242/11|
00000000|MMI|3.19|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-12-"Meds"-noun-0]|TX|3556/4|
00000000|MMI|3.19|Nebulizer Device Component|C1709156|[mnob]|["Nebulizer"-tx-2-"NEBULIZER"-noun-0]|TX|489/9|
00000000|MMI|3.19|Scientific Control|C1882979|[cnce]|["Control"-tx-31-"control"-noun-0]|TX|5342/7|
00000000|MMI|3.19|Status|C0449438|[qlco]|["Status"-tx-2-"STATUS"-noun-0]|TX|314/6|
00000000|MMI|3.19|True Control Status|C3274648|[qlco]|["Control"-tx-31-"control"-noun-0]|TX|5342/7|
00000000|MMI|3.19|control aspects|C0243148|[qlco]|["control"-tx-31-"control"-noun-0]|TX|5342/7|
00000000|MMI|3.19|control substance|C1550141|[sbst]|["Control"-tx-31-"control"-noun-0]|TX|5342/7|
00000000|MMI|3.19|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-5-"DISCHARGE DIAGNOSIS"-noun-0]|TX|2597/19|
00000000|MMI|3.18|H/O: rheumatoid arthritis|C0455571|[fndg]|["History of - rheumatoid arthritis"-tx-21-"history of rheumatoid arthritis"-noun-0]|TX|4188/10,4204/20|
00000000|MMI|3.15|Entered|C1521975|[qlco]|["Entered"-tx-35-"ENTERED"-verb-0]|TX|5556/7|
00000000|MMI|3.15|good effect|C0541990|[fndg]|["GOOD EFFECT"-tx-23-"good effect"-noun-0]|TX|4493/11|
00000000|MMI|3.15|ACSM3 gene|C1825840|[gngm]|["SA"-tx-1-"Sa"-noun-0]|TX|122/2|
00000000|MMI|3.15|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|139/7|
00000000|MMI|3.15|Axial S|C3539736|[spco]|["Sa"-tx-1-"Sa"-noun-0]|TX|122/2|
00000000|MMI|3.15|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|332/11|
00000000|MMI|3.15|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|332/11|
00000000|MMI|3.15|Focal|C0205234|[spco]|["FOCAL"-tx-19-"focal"-adj-0]|TX|4059/5|
00000000|MMI|3.15|Process|C1522240|[phpr]|["Process"-tx-21-"process"-noun-0]|TX|4131/7|
00000000|MMI|3.15|RPSA gene|C1539696|[gngm]|["SA"-tx-1-"Sa"-noun-0]|TX|122/2|
00000000|MMI|3.15|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|139/7|
00000000|MMI|3.15|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|139/7|
00000000|MMI|3.15|bony process|C1184743|[bpoc]|["Process"-tx-21-"process"-noun-0]|TX|4131/7|
00000000|MMI|3.13|Fluid, IV|C1546684|[inpr]|["Fluid, IV"-tx-29-"IV fluids"-noun-0]|TX|5151/9|
00000000|MMI|3.13|Intravenous fluid|C1289919|[sbst]|["IV Fluid"-tx-29-"IV fluids"-noun-0]|TX|5151/9|
00000000|MMI|3.13|Planned|C1301732|[ftcn]|["Plan"-tx-33-"PLAN"-noun-0]|TX|5486/4|
00000000|MMI|3.13|SS, Rat Strain|C2699257|[mamm]|["SS"-tx-12-"SS"-noun-0]|TX|3653/2|
00000000|MMI|3.13|Subject Status Domain|C3891295|[inpr]|["SS"-tx-12-"SS"-noun-0]|TX|3653/2|
00000000|MMI|3.13|Three times daily|C0556984|[tmco]|["TID"-tx-3-"TID"-noun-0]|TX|1034/3|
00000000|MMI|3.13|Treatment Plan|C0599880|[inpr]|["Plan"-tx-33-"PLAN"-noun-0]|TX|5486/4|
00000000|MMI|3.13|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-3-"TID"-noun-0]|TX|1034/3|
00000000|MMI|3.12|In addition to|C0332287|[ftcn]|["In addition to"-tx-3-"in addition to"-prep-0]|TX|1770/14|
00000000|MMI|3.11|Basal Diet|C2983588|[food]|["DIET"-tx-4-"DIET"-noun-0]|TX|2339/4|
00000000|MMI|3.11|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-4-"DIET"-noun-0]|TX|2339/4|
00000000|MMI|3.11|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-4-"DIET"-noun-0]|TX|2339/4|
00000000|MMI|3.11|About The Same|C2346711|[qlco]|["Unchanged"-tx-9-"unchanged"-adj-0]|TX|3374/9|
00000000|MMI|3.11|End|C0444930|[spco]|["End"-tx-37-"END"-noun-0]|TX|5631/3|
00000000|MMI|3.11|No status change|C0442739|[fndg]|["Unchanged"-tx-9-"unchanged"-adj-0]|TX|3374/9|
00000000|MMI|3.11|Responsible to|C1273518|[fndg]|["Responsible"-tx-5-"Responsible"-adj-0]|TX|2618/11|
00000000|MMI|3.11|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-37-"END"-noun-0]|TX|5631/3|
00000000|MMI|3.11|care activity|C1947933|[acty]|["Care"-tx-27-"care"-verb-0]|TX|4856/4|
00000000|MMI|3.10|Dose number|C1115464|[qnco]|["Dose number"-tx-3-"Number Doses"-noun-0]|TX|2103/6,2113/5|
00000000|MMI|3.10|Pre-renal acute kidney injury|C3854173|[dsyn]|["Acute renal failure"-tx-28-"acute renal failure"-noun-0]|TX|4931/19|
00000000|MMI|3.09|Admission Level of Care Code - Improved|C1561611|[inpr]|["Improved"-tx-27-"improved"-verb-0]|TX|4726/8|
00000000|MMI|3.09|Better|C0332272|[qlco]|["Improved"-tx-27-"improved"-verb-0]|TX|4726/8|
00000000|MMI|3.09|Clinical act of insertion|C0441587|[hlca]|["Placement"-tx-27-"placement"-noun-0]|TX|4810/9|
00000000|MMI|3.09|Complete|C0205197|[qlco]|["Completely"-tx-29-"completely"-adv-0]|TX|5135/10|
00000000|MMI|3.09|Improved|C0184511|[qlco]|["Improved"-tx-27-"improved"-verb-0]|TX|4726/8|
00000000|MMI|3.09|Placement|C1524072|[qlco]|["Placement"-tx-27-"placement"-noun-0]|TX|4810/9|
00000000|MMI|3.09|Placement action|C1533810|[hlca]|["Placement"-tx-27-"placement"-noun-0]|TX|4810/9|
00000000|MMI|3.09|R prime|C2603358|[clna]|["R'"-tx-5-"R"-noun-0]|TX|2977/1|
00000000|MMI|3.09|Right|C0205090|[spco]|["R-"-tx-5-"R"-noun-0]|TX|2977/1|
00000000|MMI|3.09|seen|C0205397|[qlco]|["Seen"-tx-27-"seen"-verb-0]|TX|4765/4|
00000000|MMI|3.09|Close Up|C2946173|[phsu]|["Close Up"-tx-24-"close up"-adj-0]|TX|4612/5,4625/2|
00000000|MMI|3.08|Same|C0445247|[qlco]|["SAME"-tx-3-"same"-adj-0]|TX|1756/4|
00000000|MMI|3.08|Time (foundation metadata concept)|C3541383|[tmco]|["Time"-tx-3-"time"-noun-0]|TX|1761/4|
00000000|MMI|3.08|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|194/10|
00000000|MMI|3.08|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-0]|TX|238/4|
00000000|MMI|3.07|Before|C0332152|[tmco]|["Pre"-tx-29-"pre"-adj-0]|TX|5106/3|
00000000|MMI|3.07|Before values|C0740175|[qlco]|["Pre"-tx-29-"pre"-adj-0]|TX|5106/3|
00000000|MMI|3.07|Out (direction)|C0439787|[spco]|["Out"-tx-6-"out"-prep-0]|TX|3191/3|
00000000|MMI|3.07|Pure Spanish horse breed (organism)|C3669034|[mamm]|["PRE"-tx-29-"pre"-adj-0]|TX|5106/3|
00000000|MMI|3.07|Removed|C0849355|[qlco]|["Out"-tx-6-"out"-prep-0]|TX|3191/3|
00000000|MMI|3.07|US State|C3148680|[geoa]|["State"-tx-29-"state"-noun-0]|TX|5116/5|
00000000|MMI|3.07|day|C0439228|[tmco]|["DAYS"-tx-5-"days"-noun-0]|TX|3132/4|
00000000|MMI|3.07|photoreactivating enzyme activity|C2257086|[genf]|["PRE"-tx-29-"pre"-adj-0]|TX|5106/3|
00000000|MMI|3.07|Follow|C1719822|[inpr]|["Follow"-tx-24-"follow"-adj-0]|TX|4618/6|
00000000|MMI|3.07|Followed by|C0332283|[tmco]|["follow"-tx-24-"follow"-adj-0]|TX|4618/6|
00000000|MMI|3.07|Standing position|C0231472|[phsf]|["STANDING"-tx-3-"standing"-adj-0]|TX|1785/8|
00000000|MMI|3.07|Act Mood - Goal|C1571704|[idcn]|["Goal"-tx-2-"goal"-noun-0]|TX|960/4|
00000000|MMI|3.07|Act Relationship Subset - previous|C1552607|[tmco]|["previous"-tx-2-"previous"-adj-0]|TX|968/8|
00000000|MMI|3.07|Previous|C0205156|[tmco]|["Previous"-tx-2-"previous"-adj-0]|TX|968/8|
00000000|MMI|3.06|Concern|C2699424|[idcn]|["Concern"-tx-21-"concerning"-verb-0]|TX|4275/10|
00000000|MMI|3.06|Make - Instruction Imperative|C1881534|[ftcn]|["Make"-tx-23-"made"-verb-0]|TX|4483/4|
00000000|MMI|3.06|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-0]|TX|225/3|
00000000|MMI|3.06|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|225/3|
00000000|MMI|3.03|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-16-"Abd"-adj-0]|TX|4005/3|
00000000|MMI|3.03|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-16-"Abd"-adj-0]|TX|4005/3|
00000000|MMI|3.03|Atrovent HFA|C1654826|[orch,phsu]|["Atrovent HFA"-tx-3-"ATROVENT HFA"-noun-0]|TX|1889/12|
00000000|MMI|3.03|Causing|C0678227|[ftcn]|["Causing"-tx-5-"Causing"-adj-0]|TX|2646/7|
00000000|MMI|3.03|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.03|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.03|Excellent (qualifier value)|C1961136|[qlco]|["Excellent"-tx-31-"excellent"-adj-0]|TX|5332/9|
00000000|MMI|3.03|Excellent - Specimen Quality|C1548784|[qlco]|["Excellent"-tx-31-"excellent"-adj-0]|TX|5332/9|
00000000|MMI|3.03|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.03|Mild (qualifier value)|C2945599|[qlco]|["MILD"-tx-14-"Mild"-adj-0]|TX|3961/4|
00000000|MMI|3.03|Palpable|C0522499|[qlco]|["Palpable"-tx-8-"palpable"-adj-0]|TX|3357/8|
00000000|MMI|3.03|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|263/3|
00000000|MMI|3.03|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|263/3|
00000000|MMI|3.03|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-35-"dictated"-adj-0]|TX|5539/8|
00000000|MMI|3.03|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-35-"dictated"-adj-0]|TX|5539/8|
00000000|MMI|3.03|over sedation|C0542127|[fndg]|["over sedation"-tx-3-"oversedation"-noun-0]|TX|1047/12|
00000000|MMI|3.01|4+ Answer to question|C3838679|[fndg]|["4+"-tx-3-"4"-integer-0]|TX|1628/1|
00000000|MMI|3.01|CALCIUM SUPPLEMENTS|C3540037|[phsu,vita]|["CALCIUM"-tx-26-"calcium"-noun-0]|TX|4696/7|
00000000|MMI|3.01|Calcium Drug Class|C3714611|[phsu]|["CALCIUM"-tx-26-"calcium"-noun-0]|TX|4696/7|
00000000|MMI|3.01|Calcium [EPC]|C2936886|[phsu]|["Calcium"-tx-26-"calcium"-noun-0]|TX|4696/7|
00000000|MMI|3.01|Cardiopulmonary|C0553534|[blor]|["Cardiopulmonary"-tx-21-"cardiopulmonary"-adj-0]|TX|4115/15|
00000000|MMI|3.01|ELANE wt Allele|C3538705|[gngm]|["NE"-tx-1-"Ne"-noun-0]|TX|116/2|
00000000|MMI|3.01|Full|C0443225|[qlco]|["Full"-tx-2-"Full"-adj-0]|TX|322/4|
00000000|MMI|3.01|Infusion pump Alert priority PH|C4049686|[fndg]|["PH"-tx-1-"Ph"-noun-0]|TX|119/2|
00000000|MMI|3.01|Physical Therapist - Cardiopulmonary|C1552297|[prog]|["Cardiopulmonary"-tx-21-"cardiopulmonary"-adj-0]|TX|4115/15|
00000000|MMI|3.01|Protonix|C0876139|[orch,phsu]|["Protonix"-tx-12-"Protonix"-noun-0]|TX|3752/8|
00000000|MMI|3.01|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-4-"regular exercise"-noun-0]|TX|2387/16|
00000000|MMI|3.01|Rehabilitation - specialty|C1306847|[bmod]|["Rehabilitation"-tx-2-"Rehabilitation"-noun-0]|TX|345/14|
00000000|MMI|3.01|acute|C0205178|[tmco]|["ACUTE"-tx-21-"acute"-adj-0]|TX|4109/5|
00000000|MMI|3.01|ph+|C0450407|[fndg]|["ph+"-tx-1-"Ph"-noun-0]|TX|119/2|
00000000|MMI|3.01|ph++|C0450408|[fndg]|["ph++"-tx-1-"Ph"-noun-0]|TX|119/2|
00000000|MMI|3.01|ph+++|C0450409|[fndg]|["ph+++"-tx-1-"Ph"-noun-0]|TX|119/2|
00000000|MMI|3.00|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-33-"Stable"-adj-0]|TX|5473/6|
00000000|MMI|3.00|Positive|C1446409|[qlco]|["Positive"-tx-8-"positive"-adj-0]|TX|3330/8|
00000000|MMI|3.00|Positive Charge|C2825490|[qlco]|["Positive"-tx-8-"positive"-adj-0]|TX|3330/8|
00000000|MMI|3.00|Positive Finding|C1514241|[fndg]|["POSITIVE"-tx-8-"positive"-adj-0]|TX|3330/8|
00000000|MMI|3.00|Positive Number|C3812269|[cnce]|["Positive"-tx-8-"positive"-adj-0]|TX|3330/8|
00000000|MMI|3.00|Primary|C0205225|[qlco]|["Principal"-tx-5-"PRINCIPAL"-adj-0]|TX|2587/9|
00000000|MMI|3.00|Stable status|C0205360|[qlco]|["STABLE"-tx-33-"Stable"-adj-0]|TX|5473/6|
00000000|MMI|3.00|Teaching principal|C0401925|[prog]|["Principal"-tx-5-"PRINCIPAL"-adj-0]|TX|2587/9|
00000000|MMI|3.00|percent positive cells|C0439178|[qnco]|["% Positive"-tx-8-"positive"-adj-0]|TX|3330/8|
00000000|MMI|3.00|Lorazepam 0.5 MG|C0992522|[clnd]|["Lorazepam 0.5 MG"-tx-3-"LORAZEPAM 0.5 MG"-noun-0]|TX|1949/16|
00000000|MMI|2.99|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-4-"ADA"-noun-0]|TX|2353/3|
00000000|MMI|2.99|CA8 gene|C1413051|[gngm]|["CALS"-tx-4-"cals"-noun-0]|TX|2362/4|
00000000|MMI|2.99|Genus Ada|C1060325|[plnt]|["Ada"-tx-4-"ADA"-noun-0]|TX|2353/3|
00000000|MMI|2.99|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-4-"cals"-noun-0]|TX|2362/4|
00000000|MMI|2.99|Study Day|C2826182|[tmco]|["DY"-tx-4-"dy"-noun-0]|TX|2367/2|
00000000|MMI|2.99|kilocalorie|C0439259|[qnco]|["Cal"-tx-4-"cals"-noun-0]|TX|2362/4|
00000000|MMI|2.99|Type 2|C0441730|[clas]|["Type II"-tx-5-"Type II"-noun-0]|TX|2785/7|
00000000|MMI|2.99|Intellectual scale|C0349674|[inpr]|["Scale"-tx-3-"Scale"-noun-0]|TX|1271/5|
00000000|MMI|2.99|Low Mitosis-Karyorrhexis Index|C3890211|[qnco]|["Low"-tx-3-"Low"-adj-0]|TX|1267/3|
00000000|MMI|2.99|Precursor B-cell lymphoblastic leukemia|C1292769|[neop]|["c all"-tx-3-"Call"-noun-0]|TX|1277/4|
00000000|MMI|2.99|Scale Device Component|C3536777|[mnob]|["Scale"-tx-3-"Scale"-noun-0]|TX|1271/5|
00000000|MMI|2.99|Scaling|C1947916|[acty]|["Scale"-tx-3-"Scale"-noun-0]|TX|1271/5|
00000000|MMI|2.99|Weight measurement scales|C0175659|[medd]|["Scale, NOS"-tx-3-"Scale"-noun-0]|TX|1271/5|
00000000|MMI|2.99|low|C0205251|[qlco]|["Low"-tx-3-"Low"-adj-0]|TX|1267/3|
00000000|MMI|2.99|low confidentiality|C1550472|[inpr]|["low"-tx-3-"Low"-adj-0]|TX|1267/3|
00000000|MMI|2.99|low exposure|C4048187|[qlco]|["low"-tx-3-"Low"-adj-0]|TX|1267/3|
00000000|MMI|2.99|3/5|C0442758|[qnco]|["3 5"-tx-2-"3 5"-fraction-0]|TX|501/1,505/1|
00000000|MMI|2.99|September|C3828193|[tmco]|["September"-tx-3-"September"-noun-0]|TX|2064/9|
00000000|MMI|2.99|Today|C0310367|[antb,orch]|["Today"-tx-3-"Today"-noun-0]|TX|2058/5|
00000000|MMI|2.99|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-3-"Today"-noun-0]|TX|2058/5|
00000000|MMI|2.99|0/5|C0444499|[qnco]|["0/5"-tx-2-"0.5"-fraction-0]|TX|503/3|
00000000|MMI|2.99|Baseline|C1442488|[qnco]|["Baseline"-tx-9-"baseline"-noun-0]|TX|3389/8|
00000000|MMI|2.99|June|C3829443|[tmco]|["June"-tx-34-"June"-noun-0]|TX|5515/4|
00000000|MMI|2.99|Room of building - Study|C0557651|[mnob]|["Study"-tx-5-"Study"-noun-0]|TX|2636/5|
00000000|MMI|2.99|Study|C2603343|[resa]|["Study"-tx-5-"Study"-noun-0]|TX|2636/5|
00000000|MMI|2.99|*Type - Kind of quantity|C1547052|[qnco]|["*Type"-tx-5-"Type"-noun-0]|TX|2785/4|
00000000|MMI|2.99|Administration procedure|C1533734|[topp]|["Treatment"-tx-5-"Treatment"-noun-0]|TX|2747/9|
00000000|MMI|2.99|Asthma Pathway|C2984299|[ftcn]|["Asthma"-tx-5-"asthma"-noun-0]|TX|2793/6|
00000000|MMI|2.99|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-5-"Treatment"-noun-0]|TX|2747/9|
00000000|MMI|2.99|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-5-"Treatment"-noun-0]|TX|2747/9|E02
00000000|MMI|2.99|Treating|C1522326|[ftcn]|["Treatment"-tx-5-"Treatment"-noun-0]|TX|2747/9|
00000000|MMI|2.99|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-5-"Treatment"-noun-0]|TX|2747/9|
00000000|MMI|2.99|Type - attribute|C0332307|[qlco]|["TYPE"-tx-5-"Type"-noun-0]|TX|2785/4|
00000000|MMI|2.99|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-5-"Treatment"-noun-0]|TX|2747/9|
00000000|MMI|2.99|Anxiety Scale (BASC-2)|C4050613|[inpr]|["Anxiety"-tx-3-"Anxiety"-noun-0]|TX|1977/7|
00000000|MMI|2.99|Every morning|C0585329|[tmco]|["QAM"-tx-3-"QAM"-noun-0]|TX|2005/3|
00000000|MMI|2.99|Four times daily|C0585291|[tmco]|["QID"-tx-3-"QID"-adv-0]|TX|1945/3|
00000000|MMI|2.98|Every four hours|C0585324|[tmco]|["Q4H"-tx-2-"Q4H"-noun-0]|TX|514/3|
00000000|MMI|2.98|NEB gene|C1417656|[gngm]|["NEB"-tx-2-"NEB"-noun-0]|TX|510/3|
00000000|MMI|2.98|Nebulizer solution|C1300458|[bodm]|["Neb"-tx-2-"NEB"-noun-0]|TX|510/3|
00000000|MMI|2.98|Hypophagia|C1504561|[fndg]|["Decreased PO Intake"-tx-28-"decreased PO intake"-noun-0]|TX|4958/19|
00000000|MMI|2.98|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-5-"h/o"-noun-0]|TX|3066/3|
00000000|MMI|2.97|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-5-"BRIEF"-adj-0]|TX|2987/5|
00000000|MMI|2.97|Brief|C1879313|[tmco]|["Brief"-tx-5-"BRIEF"-adj-0]|TX|2987/5|
00000000|MMI|2.97|SNF|C1548534|[spco]|["SNF"-tx-1-"SNF"-noun-0]|TX|210/3|
00000000|MMI|2.97|Shortened|C1282927|[qlco]|["brief"-tx-5-"BRIEF"-adj-0]|TX|2987/5|
00000000|MMI|2.97|Maxillary right third molar mesial prosthesis|C1552211|[medd]|["1pm"-tx-4-"1pm"-noun-0]|TX|2456/3|
00000000|MMI|2.97|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-5-"now"-adv-0]|TX|3121/3|
00000000|MMI|2.96|Close|C3810854|[fndg]|["Close"-tx-24-"close"-adj-0]|TX|4612/5|
00000000|MMI|2.96|Closed|C0587267|[ftcn]|["Close"-tx-24-"close"-adj-0]|TX|4612/5|
00000000|MMI|2.96|Partial Metabolic Response|C4050178|[fndg]|["PMR"-tx-24-"PMR"-noun-0]|TX|4603/3|
00000000|MMI|2.96|Possible|C0332149|[qlco]|["Possible"-tx-24-"possible"-adj-0]|TX|4594/8|
00000000|MMI|2.96|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-24-"possible"-adj-0]|TX|4594/8|
00000000|MMI|2.96|Possibly Related to Intervention|C1705910|[qlco]|["Possible"-tx-24-"possible"-